Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>:Unit Recently Received Approval From Nmpa Of People'S Republic Of China For Clinical Trial Of Xh-S004 Tablets.Further Company Coverage: 600196.Ss. ((Reuters.Briefs@Thomsonreuters.Com;)).
Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>:Unit Recently Received Approval From Nmpa Of People'S Republic Of China For Clinical Trial Of Xh-S004 Tablets.Further Company Coverage: 600196.Ss. ((Reuters.Briefs@Thomsonreuters.Com;)).
Comments